Thursday, May 20th

Satellite Session:

Sponsored Symposium by Novartis 

Moderator: Dr. Adi Shacahm-Abulafia

14:30 - 15:00 Update on adequate diagnosis and treatment of advanced systemic                                     mastocytosis

                         Dr. Andreas Reiter

Opening Remarks and Greetings

15:00 - 15:30

Dr. Pia Raanani, Head, Institute of Hematology, Davidoff Cancer Center,

Rabin Medical Center, Israel

Dr. Eytan Wirtheim, CEO, Rabin Medical Center, Israel

Dr. Martin Ellis, Chairman, The Israeli Society of Hematology

Dr. Ehud Grossman, Dean, The Sackler Faculty of Medicine at Tel Aviv University,

Dr. Gal Markel, Head, Davidoff Cancer Center, Rabin Medical Center, Israel

Session 1

Acute lymphoblastic leukemia

Moderator: Dr. Ofir Wolach

15:30 - 15:50 Adult ALL in 2021- progress in research and therapy

                         Dr. Hagop Kantarjian

15:50 - 16:10 ALL - towards an almost more personalized management

                         Dr. Robin Foa

16:10 - 16:30 Q&A panel

16:30 - 16:50 Special Lecture: Immunotherapy in forgotten patients: when practice makes  


                         Dr. Gal Markel

16:50 - 17:10  Coffee break & pitch the crowd

Pitch the crowd

16:50 - 16:55 Novartis Presents-

                         Guidelines for suspected ITP – cooperation with the Israeli society of Internal                             medicine

16:55 - 17:00 Abbvie Presnets - 

                         Clonal dynamics after venetoclax-obinutuzumab therapy for CLL - 

                         insights from the randomized phase III CLL-14 study

                         Dr. Shimrit Ringelstein Harlev

Session 2

Lymphoproliferative disorders

Moderator: Dr. Tamar Tadmor

17:10 - 17:30 Tailoring maintenance therapy of myeloma

                        Dr. Morie Gertz

17:30 - 17:50 BTK inhibitors for CLL therapy: better alone or in combination?

                        Sponsored by Janssen (independent sponsorship)

                        Dr. Jan Burger

17:50 - 18:10 Q&A panel

18:10 - 18:30 Special Lecture: The missing puzzle:  case management in cardio-oncology

                         Dr. Osnat Itzhaki

18:30 - 18:50 Coffee break 

Session 3

Acute myeloid leukemia

Moderator: Dr. Yishai Ofran

18:50 - 19:10 Evidence is mounting that practice is changing in AML

                        Sponsored by Medison (independent sponsorship)

                        Dr. Richard Stone

19:10 - 19:30 Managing intensive-chemotherapy ineligible patients with AML

                        Dr. Courtney DiNardo

19:30 - 19:50 Q&A panel

19:50 - 20:10 Special lecture: Epitranscriptomics - from basic research to therapy

                         Dr. Gidi Rechavi

20:10 - 20:15 Closing remarks

Satellite Session:

Sponsored Symposium by AstraZeneca
Moderator: Dr. Gilad Itchaki

20:15 - 20:45 CLL in COVID-19 Era

                         Dr. Tamar Tadmor

לוגו אוניברסיטת תל-אביב.png
איגוד ההמטולוגיה.jpg
האגודה למלחמה בסרטן.jpg
מרכז דוידוף.jpg